GelStat Corporation (GSAC)
OTHER OTC:GSAC
GSAC Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume1.20M
Average Volume (3M)N/A
Market Cap
$1.12M
Enterprise Value$1.03M
Total Cash (Recent Filing)$71.41K
Total Debt (Recent Filing)$849.62K
Price to Earnings (P/E)―
Beta0.85
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding3,740,435,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-0.86
Price to Sales (P/S)2.57
P/FCF Ratio-15.69
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue3.26
Enterprise Value/Gross Profit4.92
Enterprise Value/Ebitda-12.24
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GSAC FAQ
What was GelStat Corporation’s price range in the past 12 months?
Currently, no data Available
What is GelStat Corporation’s market cap?
GelStat Corporation’s market cap is $1.12M.
When is GelStat Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GelStat Corporation’s earnings last quarter?
Currently, no data Available
Is GelStat Corporation overvalued?
According to Wall Street analysts GelStat Corporation’s price is currently Overvalued.
Does GelStat Corporation pay dividends?
GelStat Corporation does not currently pay dividends.
What is GelStat Corporation’s EPS estimate?
GelStat Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GelStat Corporation have?
GelStat Corporation has 3,740,435,000 shares outstanding.
What happened to GelStat Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GelStat Corporation?
Currently, no hedge funds are holding shares in GSAC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GelStat Corporation
GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.